1. Home
  2. HMST vs RIGL Comparison

HMST vs RIGL Comparison

Compare HMST & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HMST
  • RIGL
  • Stock Information
  • Founded
  • HMST 1921
  • RIGL 1996
  • Country
  • HMST United States
  • RIGL United States
  • Employees
  • HMST N/A
  • RIGL N/A
  • Industry
  • HMST Major Banks
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • HMST Finance
  • RIGL Health Care
  • Exchange
  • HMST Nasdaq
  • RIGL Nasdaq
  • Market Cap
  • HMST 287.6M
  • RIGL 271.5M
  • IPO Year
  • HMST 2012
  • RIGL 2000
  • Fundamental
  • Price
  • HMST $9.26
  • RIGL $14.20
  • Analyst Decision
  • HMST Hold
  • RIGL Buy
  • Analyst Count
  • HMST 3
  • RIGL 4
  • Target Price
  • HMST $11.83
  • RIGL $31.13
  • AVG Volume (30 Days)
  • HMST 156.4K
  • RIGL 88.9K
  • Earning Date
  • HMST 10-29-2024
  • RIGL 11-07-2024
  • Dividend Yield
  • HMST 4.41%
  • RIGL N/A
  • EPS Growth
  • HMST N/A
  • RIGL N/A
  • EPS
  • HMST N/A
  • RIGL N/A
  • Revenue
  • HMST $169,710,000.00
  • RIGL $130,201,000.00
  • Revenue This Year
  • HMST N/A
  • RIGL $38.26
  • Revenue Next Year
  • HMST $13.12
  • RIGL $24.21
  • P/E Ratio
  • HMST N/A
  • RIGL N/A
  • Revenue Growth
  • HMST N/A
  • RIGL 7.48
  • 52 Week Low
  • HMST $4.90
  • RIGL $7.48
  • 52 Week High
  • HMST $16.10
  • RIGL $17.30
  • Technical
  • Relative Strength Index (RSI)
  • HMST 14.79
  • RIGL 44.95
  • Support Level
  • HMST $8.72
  • RIGL $13.57
  • Resistance Level
  • HMST $14.54
  • RIGL $14.70
  • Average True Range (ATR)
  • HMST 0.36
  • RIGL 0.55
  • MACD
  • HMST -0.67
  • RIGL -0.19
  • Stochastic Oscillator
  • HMST 7.70
  • RIGL 27.27

About HMST HomeStreet Inc.

HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: